Management and outcome of bilateral testicular germ cell tumors: Twenty-five year experience in Munich

Acta Oncologica

Volumn 44, Issue 6, 2005, Pages 529-536

  Hentrich, Marcus ^a,c   Weber, Norbert ^b   Bergsdorf, Thorsten ^a   Liedl, Bernhard ^c   Hartenstein, Reiner ^a   Gerl, Arthur ^b,c  

^a Munich Harlaching Hospital   (Germany)

^b Oncological Practice   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BILATERAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FOLLOW UP; GERM CELL TUMOR; HUMAN; MEDICAL LITERATURE; ORCHIECTOMY; PRIORITY JOURNAL; REVIEW; SEMINOMA; TESTIS CARCINOMA; TESTIS TUMOR;

ADOLESCENT; ADULT; BIOPSY; COMBINED MODALITY THERAPY; HUMANS; MALE; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; ORCHIECTOMY; PROGNOSIS; SEMINOMA; TESTICULAR NEOPLASMS; TESTIS; TREATMENT OUTCOME;

EID: 27144496351     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860510029923     Document Type: Review

References (49)

1. Scheiber K, Ackermann D, Studer UE. Bilateral testicular germ cell tumors: a report of 20 cases. J Urol 1987;138: 73-6.
2. Fossa SD, Aass N. Cisplatin-based chemotherapy does not eliminate the risk of a second testicular cancer. Br J Urol 1989;63:531-4.
3. Osterlind A, Berthelsen JG, Abildgaard N, Hansen SO, Hjalgrim H, Johansen B, et al. Risk of bilateral testicular germ cell cancer in Denmark -1984. J Natl Cancer Inst; 83 1960;1991:1391-5.
4. Dieckmann K-P, Loy V, Büttner P. Prevalence of bilateral testicular germ cell tumours and early detection based on contralateral testicular intra-epithelial neoplasia. Br J Urol 1993;71:340-5.
5. Coogan CL, Foster RS, Simmons GR, Tognoni PG, Roth BJ, Donohue JP. Bilateral testicular tumors. Management and outcome in 21 patients. Cancer 1998;83:547-52.
6. Che M, Tamboli P, Ro JY, Park DS, Ro S, Amato RJ, et al. Bilateral testicular germ cell tumors. Twenty-year experience at M.D. Anderson Cancer Center. Cancer 2002;95: 1228-33.
7. Celebi I, Tekgül S, Özen HA, Özgu I, Remzi D. Sequential bilateral germ cell tumours of the testis. Int Urol Nephrol 1995;27:183-7.
8. Colls BM, Harvey VJ, Skelton L, Thompson PI, Frampton CM. Bilateral germ cell testicular tumors in New Zealand: experience in Auckland and Christchurch 1978-1994. J Clin Oncol 1996;14:2061-5.
9. Van Basten JA, Hoekstra HJ, van Driel MF, Sleijfer DT, Droste JHJ, Schraffordt Koops H. Cisplatin-based chemotherapy changes the incidence of bilateral testicular cancer. Ann Surg Oncol 1997;4:342-8.
10. Gerl A, Clemm Ch, Kohl P, Wilmanns W. Testicular tumor after cisplatin-based chemotherapy for germ cell malignancy. Eur Urol 1994;25:216-9.
11. Von der Maase H, Rorth M, Walbom-Jorgensen S, Sorensen BL, Christophersen IS, Hald T, et al. Carcinoma in situ of contra-lateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br Med J 1986; 293:1398-401.
12. Dieckmann K-P, Loy V. Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms. J Clin Oncol 1996;14:3126-32.
13. Daugaard G, Giwercman A, Skakkebaek NE. Should the other testis be biopsied? Sem Urol Oncol 1996;14:8-12.
14. Herr HW, Sheinfeld J. Is biopsy of the contralateral testis necessary in patients with germ cell tumors? J Urol 1997; 158:1331-4.
15. Petersen PM, Giwercman A, Daugaard G, Rorth M, Petersen JH, Skakkebaek NE, et al. Effect of graded testicular dose of radiotherapy in patients treated for carcinoma-in situ in the testis. J Clin Oncol 2002;20: 1537-43.
16. Classen J, Dieckmann K, Bamberg M, Souchon R, Kliesch S, Kuehn M, et al. Radiotherapy with 16 Gy may fail to eradicate testicular intraepithelial neoplasia: preliminary communication of a dose-reduction trial of the German Testicular Cancer Study Group. Br J Cancer 2003;88: 828-31.
17. Dötsch M, Brauers A, Büttner R, Nolte-Ernsting C, Eble MJ, Jakse G. Malignant germ cell tumour of the contralateral testis after radiotherapy for testicular intraepithelial neoplasia. J Urol 2000;164:452-3.
18. Dieckmann KP, Lauke H, Michl U, Winter E, Loy V. Testicular germ cell cancer despite previous local radiotherapy to the testis. Eur Urol 2002;41:643-50.
19. Bach DW, Weissbach L, Hartlapp JH. Bilateral testicular tumor. J Urol 1983;129:989-91.
20. Kristianslund S, Fossa SD, Kjellevold K. Bilateral malignant testicular germ cell cancer. Br J Urol 1986;58:60-3.
21. Thompson J, Williams CJ, Whitehouse JMA, Mead GM. Bilateral testicular germ cell tumors: an increasing incidence and prevention by chemotherapy. Br J Urol 1988;62:374-6.
22. Wahl Ch, Hedinger C. Bilaterale Keimzelltumoren des Hodens. Schweiz med Wschr 1988;12:427-33.
23. Patel SR, Richardson RL, Kvols L. Synchronous and metachronous bilateral testicular tumors. Mayo clinic experience. Cancer 1990;65:1-4.
24. Erpenbach K, Derschum W, Reis M, von Vietsch H. Ergebnisse einer engmaschigen Hodentumornachsorge. Urologe [A] 1990;29:102-7.
25. Fordham MVP, Mason MD, Blackmore C, Hendry WF, Horwich A. Management of the contralateral testis in patients with testicular germ cell cancer. Br J Urol 1990; 65:290-3.
26. Kratzik C, Aiginger P, Kuber W, Riccabona M, Kührer I, Joos H, et al. Risk factor for bilateral testicular germ cell tumors. Does heredity play a role? Cancer 1991;68: 916-21.
27. Bokemeyer C, Schmoll HJ, Schöffski P, Harstrick A, Bading M, Poliwoda H. Bilateral testicular tumors: prevalence and clinical implications. Eur J Cancer 1993;29A:874-6.
28. Heidenreich A, Bonfig R, Derschum W, von Vietsch H, Wilbert DM. A conservative approach to bilateral testicular germ cell tumors. J Urol 1995;153:10-3.
29. Sonneveld DJA, Schraffordt-Koops H, Sleijfer DT, Hoekstra HJ. Bilateral testicular germ cell tumours in patients with initial stage I disease. Prevalence and prognosis. A single center's 30 years experience. Eur J Cancer 1998;34:1363-7.
30. Albers P, Göll A, Bierhoff E, Schoeneich G, Müller SC. Clinical course and histo-pathologic risk factor assessment in patients with bilateral testicular germ cell tumors. Urology 1999;54:714-8.
31. Tekin A, Aygun YC, Aki FT, Ozen H. Bilateral germ cell cancer of the testis: a report of 11 patients with a long term follow-up. BJU International 2000;85:864-8.
32. Van der Poel HG, Sederlaar JPM, Debruyne FMJ, Witjes JA. Recurrence of germ cell tumor after orchiectomy. Urology 2000;56:467-73.
33. Ondrus D, Hornak M, Mat'oska J. Bilateral testicular germ-cell tumors - a single centre long-term experience. Int Urol Nephrol 2001;33:521-4.
34. Ohyama C, Kyan A, Satoh M, Saito S, Nishimura Y, Imai Y, et al. Bilateral testicular tumors: a report of nine cases with long-term follow-up. Int J Urol 2002;9:173-7.
35. Géczi L, Gomez F, Bak M, Bodrogi I. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary. J Cancer Res Clin Oncol 2003;129: 309-15.
36. Pamenter B, De Bono JS, Brown IL, Nandini M, Kaye SB, Russell JM, et al. Bilateral testicular cancer: a preventable problem? Experience from a large cancer center. BJU Int 2003;92:43-6.
37. Holzbeierlein JM, Sogani PC, Sheinfeld J. Histology and clinical outcomes in patients with bilateral testicular germ cell tumors: the Memorial Sloan Kettering Cancer Center experience 1950 to 2001. J Urol 2003;169:2122-5.
38. Hoff Wanderas E, Fossa SD, Tretli S. Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients. Eur J Cancer 1997;33: 244-52.
39. Christensen TB, Daugaard G, Geertsen PF, von der Maase H. Effect of chemotherapy on carcinoma in situ of the testis. Ann Oncol 1998;9:657-60.
40. von Ostau C, Krege S, Hartmann M, Rübben H. Metachronous contralateral germ cell tumor 7 years after management of testicular intraepithelial neoplasia by chemotherapy and multiple control biopsies. Scand J Urol Nephrol 2001; 35:430-1.
41. Kliesch S, Bergmann M, Hertle L, Nieschlag E, Behre HM. Semen parameters and testicular pathology in men with testicular cancer and contralateral carcinoma in situ or bilateral testicular malignancies. Hum Reprod 1997;12: 2830-5.
42. Heidenreich A, Vorreuther R, Neubauer S, Zumbe J, Engelmann UH. Paternity in patients with bilateral testicular germ cell tumors. Eur Urol 1997;31:246-8.
43. Jacobsen KD, Fossa SD, Bjoro TP, Aass N, Heilo A, Stenwig AE. Gonadal function and fertility in patients with bilateral testicular germ cell malignancy. Eur Urol 2002;42:229-38.
44. Harland SJ, Cook PA, Fossa S, Horwich A, Mead GM, Parkinson MC, et al. Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: defining a high risk group. J Urol 1998;160:1353-7.
45. Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, Kollmannsberger C, et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004;15:1377-99.
46. Dieckmann K-P, Hamm B, Due W, Bauer HW. Simultaneous bilateral testicular germ cell tumors with dissimilar histology: case report and review of the literature. Urol Int 1988;43:305-9.
47. Redmond J, Samaha MA, Charles RS, Vukelja SJ, Faragher D, Tenglin R, et al. Bilateral synchronous testicular germ cell cancer. South Med J 1995;88:305-8.
48. Weissbach L. Organ preserving surgery of malignant germ cell tumors. J Urol 1995;153:90-3.
49. Heidenreich A, Weißbach L, Höltl W, Albers P, Kliesch S, Köhrmann KU, et al. Organ sparing surgery for malignant germ cell tumor of the testis. J Urol 2001;166:2161-5.